NASDAQ:TCON - TRACON Pharmaceuticals Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$0.66 +0.01 (+1.54 %)
(As of 04/26/2019 08:00 AM ET)
Previous Close$0.66
Today's Range$0.64 - $0.66
52-Week Range$0.50 - $3.20
Volume121,600 shs
Average Volume478,968 shs
Market Capitalization$19.73 million
P/E RatioN/A
Dividend YieldN/A
Beta3.1

Analyst Ratings

TRACON Pharmaceuticals (NASDAQ:TCON) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
2 Wall Street analysts have issued ratings and price targets for TRACON Pharmaceuticals in the last 12 months. Their average twelve-month price target is $8.00, suggesting that the stock has a possible upside of 1,112.12%. The high price target for TCON is $9.00 and the low price target for TCON is $7.00. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.503.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $8.00$8.00$8.50$8.00
Price Target Upside: 1,112.12% upside614.29% upside1,340.68% upside220.00% upside

TRACON Pharmaceuticals (NASDAQ:TCON) Consensus Price Target History

Price Target History for TRACON Pharmaceuticals (NASDAQ:TCON)

TRACON Pharmaceuticals (NASDAQ:TCON) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/12/2019BTIG ResearchDowngradeBuy ➝ NeutralHighView Rating Details
3/1/2019Needham & Company LLCReiterated RatingBuy ➝ Buy$7.00HighView Rating Details
6/13/2017Stifel NicolausLower Price TargetBuy ➝ Buy$14.00 ➝ $6.00HighView Rating Details
(Data available from 4/26/2017 forward)
This page was last updated on 4/26/2019 by MarketBeat.com Staff

Featured Article: Fiduciary

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel